UCLA, California, United States
Dr. Robert Damoiseaux’s main interests are at the interface of chemistry, biology and engineering and include the development of novel assay technology platforms, High Throughput Screening, High Content Screening and nanotechnology. After having earned a Ph.D. degree at the University of Lausanne (Switzerland) where he worked on directed molecular evolution of antibodies he joined the Novartis Institute for Functional Genomics (GNF) in La Jolla, CA in 2001. Since 2004 he is the Director of the Molecular Shared Screening Resources (MSSR) – a unique state of the art screening facility at the California NanoSystems Institute of UCLA where he directs all drug discovery as well as the functional genomics projects. His private research focuses on novel assay systems and toxicological issues of small molecules and nano-materials and consults for the pharmaceutical industry.
Disclosure information not submitted.
Tuesday, February 8, 2022
3:00 PM – 4:00 PM